C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/18/2011	US8039609 Aptamers directed to MUC1
10/18/2011	US8039608 Bioinformatically detectable group of novel regulatory genes and uses thereof
10/18/2011	US8039606 Seneca Valley virus based compositions and methods for treating disease
10/18/2011	US8039602 Nucleotide sequences coding polypeptide for use in the diagnosis treatment and prevention of tumors
10/18/2011	US8039600 Monoclonal antibodies
10/18/2011	US8039599 Rapamycin assay
10/18/2011	US8039587 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector
10/18/2011	US8039586 Cerebral organic anion transporter and its gene
10/18/2011	US8039446 Compounds for the modulation of beta-catenin expression
10/18/2011	US8039445 Methods and devices for delivering a therapeutic product to the ocular sphere of a subject
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	US8039437 Fn14/TRAIL fusion proteins
10/18/2011	US8039429 Method of treatment using high-affinity antagonists of ELR-CXC chemokines
10/18/2011	US8039271 For real-time, interactive spatial manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution
10/18/2011	US8039261 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
10/18/2011	US8039260 Maize progenitor cell mixtures for use as tool in identifying herbicides, enhancing photosynthesis, plastid transformation and genetic manipulation
10/18/2011	US8039259 Buffer solution for electroporation and a method comprising the use of the same
10/18/2011	US8039241 Thermostable alpha-amylases
10/18/2011	US8039238 Transgenic cell comprising vector which codes lactate dehydrogenase; controlling production of lactic acid and ethanol
10/18/2011	US8039237 Bioabsorbable polymer containing 2-hydroxyacid monomers
10/18/2011	US8039236 Process for producing dipeptides
10/18/2011	US8039233 Nucleic acid sequences and their use in methods to identify umami modulatiors
10/18/2011	US8039232 Method for producing a dipeptide
10/18/2011	US8039230 Selection of host cells expressing protein at high levels
10/18/2011	US8039224 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
10/18/2011	US8039217 Identification of markers for disease including epitopes is effected in the presence of simulated redox state perturbations
10/18/2011	US8039209 Yeast screens for treatment of human disease
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038995 Human N-type calcium channel isoform and uses thereof
10/18/2011	CA2506329C Candida kefyr cytosine deaminase
10/18/2011	CA2492917C Compositions and methods for the modulation of gene expression in plants
10/18/2011	CA2490163C 5t4 antigen expression as a marker for stem cell differentiation
10/18/2011	CA2465156C Il-21 antagonists
10/18/2011	CA2463905C Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/18/2011	CA2433495C Methods of examining ability to control nerve cell plasticity
10/18/2011	CA2381708C Immunogenic protein against piscirickettsia salmonis
10/18/2011	CA2378326C Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants
10/18/2011	CA2364934C Method for obtaining a purified viral preparation
10/18/2011	CA2350837C .alpha.-amylase variants
10/18/2011	CA2328515C Continuous in-vitro evolution
10/18/2011	CA2323572C Vertebrate patched-2 protein
10/18/2011	CA2252986C Process for preparing functional recombinant tissue factor
10/18/2011	CA2232237C Reagents and methods useful for detecting diseases of the breast
10/18/2011	CA2228944C Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/18/2011	CA2176266C Detectably labeled dual conformation oligonucleotide probes, assays and kits
10/16/2011	CA2737014A1 Novel t7 rna polymerase variants with enhanced thermostability
10/13/2011	WO2011127418A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof
10/13/2011	WO2011127393A2 Variants of ancestral uricases and uses thereof
10/13/2011	WO2011127340A2 Viral-based transient-expression vector system that allows multiple applications
10/13/2011	WO2011127337A2 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
10/13/2011	WO2011127307A1 Modulation of cetp expression
10/13/2011	WO2011127299A1 Methods for the treatment of autoimmune diseases
10/13/2011	WO2011127222A1 Diagnosis and treatment of melanoma through nuak2 assessment and modulation
10/13/2011	WO2011127175A1 Modulation of cd130 (gp130) expression
10/13/2011	WO2011127088A2 Methods and compositions for decreasing chronic pain
10/13/2011	WO2011126864A2 Cancer treatment with recombinant vector
10/13/2011	WO2011126811A2 High level expression of recombinant toxin proteins
10/13/2011	WO2011126808A2 Pharmacologically induced transgene ablation system
10/13/2011	WO2011126768A2 Methods and materials for detecting colorectal cancer and adenoma
10/13/2011	WO2011126644A2 Plant peptide gamma-zein for delivery of biomolecules into plant cells
10/13/2011	WO2011126576A2 Genetic signatures in the envelope glycoprotein of hiv-1
10/13/2011	WO2011126238A2 Aboveground organ specific promoters for transforming plants and uses thereof
10/13/2011	WO2011126126A1 NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF
10/13/2011	WO2011126105A1 Test method for determining susceptibility to or state of immune system disorder or joint disorder
10/13/2011	WO2011126089A1 Method of detecting rhabdomyosarcoma using sample derived from body fluid
10/13/2011	WO2011126048A1 Method for detecting genetic abnormalities in neuroblastoma using sample derived from body fluid
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	WO2011125948A1 Method for preparing es cells
10/13/2011	WO2011125943A1 Modified oligonucleotide
10/13/2011	WO2011125875A1 Novel monoclonal antibody and method for immunoassaying d dimer
10/13/2011	WO2011125852A1 Nucleic acid structure, method for producing complex using same, and screening method
10/13/2011	WO2011125833A1 Constitution of tool for analyzing biomolecular interaction and analysis method using same
10/13/2011	WO2011125785A1 Novel allene oxide synthase derived from lemna paucicostata
10/13/2011	WO2011125748A1 Polynucleotides encoding nf-yb originating in jatropha and utilization thereof
10/13/2011	WO2011125469A1 Micro-rna-regulated recombinant vaccinia virus and utilization thereof
10/13/2011	WO2011125467A1 Plasmid vector
10/13/2011	WO2011125334A1 Cdca5 peptides and vaccines including the same
10/13/2011	WO2011125245A1 Method for prediction of prognosis of small cell lung cancer, method for treatment of small cell lung cancer, method for amelioration of prognosis of small cell lung cancer, and method for screening for therapeutic agent for small cell lung cancer, each utilizing mirna
10/13/2011	WO2011125139A1 Cluap1 peptides and vaccines including the same
10/13/2011	WO2011125054A2 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
10/13/2011	WO2011125034A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals
10/13/2011	WO2011124899A1 Cell poration
10/13/2011	WO2011124869A1 Self-assembling half-antibodies
10/13/2011	WO2011124718A1 Albumin derivatives and variants
10/13/2011	WO2011124709A1 Chromatographic device and method for isolating and purifying nucleic acids
10/13/2011	WO2011124708A1 Method for precipitating anionic surfactant ions in the presence of nucleic acids
10/13/2011	WO2011124705A1 Method for isolating and purifying nucleic acids
10/13/2011	WO2011124703A1 Method for selective isolation and purification of nucleic acids
10/13/2011	WO2011124693A1 Method of generating gene mosaics
10/13/2011	WO2011124653A1 Method and kit for separating viral and prokaryotic nucleic acids from eukaryotic nucleic acids
10/13/2011	WO2011124635A1 Binding molecules against chikungunya virus and uses thereof
10/13/2011	WO2011124371A1 Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof
10/13/2011	WO2011124146A1 Yeast having improved ethanol yield
10/13/2011	WO2011124056A1 Genetically engineered vaccine against lymphocystis disease in paralichthys olivaceus and method for producing the same
10/13/2011	WO2011124029A1 Key genes, micrornas, other non-coding rnas and combinations thereof for identifying and regulating pluripotency of cells
10/13/2011	WO2011123945A1 Compostions, methods and uses for treating respiratory syncytial virus infection
10/13/2011	WO2011123903A1 Chemokine receptor heteromultimers, compounds that bind thereto and uses thereof
10/13/2011	WO2011090753A3 Alcohol dehydrogenases (adh) useful for fermentive production of lower alkyl alcohols

1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 4023